| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer
|
Akerley, Wallace
|
|
2008
|
9 |
Supplement 1 |
p. 306-
1 p.
|
artikel
|
| 2 |
Addressing the Current Challenges of Non–Small-Cell Lung Cancer Clinical Trial Accrual
|
Curran Jr, Walter J.
|
|
2008
|
9 |
Supplement 1 |
p. 222-226
5 p.
|
artikel
|
| 3 |
A Phase II Study of Erlotinib as a First-Line Therapy for Patients with Non—Small-Cell Lung Cancer with Favorable Clinical Predictors
|
Lee, Dae Ho
|
|
2008
|
9 |
Supplement 1 |
p. 297-
1 p.
|
artikel
|
| 4 |
A Randomized Phase II Trial of Oral Topotecan Versus Docetaxel in the Second-Line Treatment of Non–Small-Cell Lung Cancer
|
Jones, Suzanne
|
|
2008
|
9 |
Supplement 1 |
p. 154-159
6 p.
|
artikel
|
| 5 |
Assessment of Guilt and Shame in Patients with Non–Small-Cell Lung Cancer Compared with Patients with Breast and Prostate Cancer
|
LoConte, Noelle K.
|
|
2008
|
9 |
Supplement 1 |
p. 171-178
8 p.
|
artikel
|
| 6 |
BRCA1: A New Genomic Marker for Non–Small-Cell Lung Cancer
|
Reguart, Noemí
|
|
2008
|
9 |
Supplement 1 |
p. 331-339
9 p.
|
artikel
|
| 7 |
Can We Customize Chemotherapy? Individualizing Cytotoxic Regimens in Advanced Non–Small-Cell Lung Cancer
|
Rosell, Rafael
|
|
2008
|
9 |
Supplement 1 |
p. S76-S82
7 p.
|
artikel
|
| 8 |
Can We Detect Lung Cancer Earlier by Measurement of Serum C-Reactive Protein, Carcinoembryonic Antigen, and Cell-Free Plasma DNA?
|
Son, Choonhee
|
|
2008
|
9 |
Supplement 1 |
p. 301-
1 p.
|
artikel
|
| 9 |
Chemotherapy for Brain Metastases in Small-Cell Lung Cancer
|
Chen, Gigi
|
|
2008
|
9 |
Supplement 1 |
p. 35-38
4 p.
|
artikel
|
| 10 |
Current State of Vaccine Therapies in Non–Small-Cell Lung Cancer
|
Romero, Pedro
|
|
2008
|
9 |
Supplement 1 |
p. S28-S36
9 p.
|
artikel
|
| 11 |
Emerging Safety Data for Bevacizumab in Advanced Non–Small-Cell Lung Cancer
|
Hirsh, Vera
|
|
2008
|
9 |
Supplement 1 |
p. S62-S70
9 p.
|
artikel
|
| 12 |
Exosomal microRNA: A Diagnostic Marker for Lung Cancer
|
Kloecker, Goetz H.
|
|
2008
|
9 |
Supplement 1 |
p. 295-
1 p.
|
artikel
|
| 13 |
Fractionated Stereotactic Body Radiation Therapy in the Treatment of Primary, Recurrent, and Metastatic Lung Tumors: The Role of Positron Emission Tomography/Computed Tomography–Based Treatment Planning
|
Coon, Devin
|
|
2008
|
9 |
Supplement 1 |
p. 217-221
5 p.
|
artikel
|
| 14 |
Metronomic Chemotherapy in Patients with Advanced Non—Small-Cell Lung Cancer Associated with Long-Term Survival
|
Chen, Nick
|
|
2008
|
9 |
Supplement 1 |
p. 290-
1 p.
|
artikel
|
| 15 |
Patterns of Radiation Therapy Practice in Nonmetastatic Non—Small-Cell Lung Cancer: Results of Web-Based Patterns of Care Study in Korea
|
Wu, Hong-Gyun
|
|
2008
|
9 |
Supplement 1 |
p. 304-
1 p.
|
artikel
|
| 16 |
Phase I Study of Flavopiridol in Combination with Paclitaxel and Carboplatin in Patients with Non–Small-Cell Lung Cancer
|
George, Saby
|
|
2008
|
9 |
Supplement 1 |
p. 160-165
6 p.
|
artikel
|
| 17 |
Population Characteristics and Prognostic Factors in Metastatic Non–Small-Cell Lung Cancer: A Fox Chase Cancer Center Retrospective
|
Paralkar, Vikram R.
|
|
2008
|
9 |
Supplement 1 |
p. 116-121
6 p.
|
artikel
|
| 18 |
Preliminary Treatment Patterns and Safety Outcomes for Non—Small-Cell Lung Cancer from ARIES, a Bevacizumab Treatment Observational Cohort Study
|
Spigel, David
|
|
2008
|
9 |
Supplement 1 |
p. 302-
1 p.
|
artikel
|
| 19 |
Restrictive Eligibility Limits Access to Newer Therapies in Non–Small-Cell Lung Cancer: The Implications of Eastern Cooperative Oncology Group 4599
|
Somer, Robert A.
|
|
2008
|
9 |
Supplement 1 |
p. 102-105
4 p.
|
artikel
|
| 20 |
Rhabdomyolysis Resulting from Pharmacologic Interaction Between Erlotinib and Simvastatin
|
Veeraputhiran, Muthu
|
|
2008
|
9 |
Supplement 1 |
p. 232-234
3 p.
|
artikel
|
| 21 |
Selected Clinical Trials in Non–Small-Cell Lung Cancer
|
|
|
2008
|
9 |
Supplement 1 |
p. 375-376
2 p.
|
artikel
|
| 22 |
Sunitinib plus Erlotinib for the Treatment of Metastatic Non—Small-Cell Lung Cancer: A Novel VEGFR—EGFR Co-Inhibition Treatment Strategy
|
Scagliotti, Giorgio V.
|
|
2008
|
9 |
Supplement 1 |
p. 300-
1 p.
|
artikel
|
| 23 |
Symptom Concerns and Use of Supportive Services in Patients with Lung Cancer
|
Borneman, Tami
|
|
2008
|
9 |
Supplement 1 |
p. 288-
1 p.
|
artikel
|
| 24 |
The Clinical Development of Vandetanib: Updates on Ongoing Phase III Clinical Trials in Advanced Non—Small-Cell Lung Cancer
|
Heymach, John
|
|
2008
|
9 |
Supplement 1 |
p. 292-
1 p.
|
artikel
|
| 25 |
Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients with Non–Small-Cell Lung Cancer
|
Koldas, Macit
|
|
2008
|
9 |
Supplement 1 |
p. 112-115
4 p.
|
artikel
|
| 26 |
Tracheoesophageal Fistula Development and Concurrent Chemoradiation and Bevacizumab in Non—Small-Cell Lung Cancer
|
Spigel, David R.
|
|
2008
|
9 |
Supplement 1 |
p. 303-
1 p.
|
artikel
|
| 27 |
Weekly Paclitaxel in Elderly Patients (Aged ≥ 70 Years) with Advanced Non–Small-Cell Lung Cancer: An Alternative Choice? Results of a Phase II Study
|
Rossi, David
|
|
2008
|
9 |
Supplement 1 |
p. 280-284
5 p.
|
artikel
|
Tijdschrift beschrijving